At a glance
- Originator Servier
- Class Antihypertensives
- Mechanism of Action Endothelin-converting enzyme 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral vasospasm; Hypertension; Myocardial infarction; Renal failure
Most Recent Events
- 12 Jun 2001 No-Development-Reported for Cerebral vasospasm in France (PO)
- 12 Jun 2001 No-Development-Reported for Hypertension in France (PO)
- 12 Jun 2001 No-Development-Reported for Myocardial infarction in France (PO)